Michael J. Hafey
United States Military Academy(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies, HIV/AIDS drug development and treatment, Drug-Induced Hepatotoxicity and Protection, Biochemical and Molecular Research
Most-Cited Works
- → Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex(2004)761 cited
- → Membrane transporters in drug development and as determinants of precision medicine(2024)189 cited
- → Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein(2007)175 cited
- → Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia(2011)141 cited
- → Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective(2018)113 cited
- → Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors(2015)36 cited
- → Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure(2009)28 cited
- → Antibiotic-induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition(2017)24 cited
- → Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters(2021)24 cited
- → Discovery of MK‐8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption(2014)22 cited